# RCT Study to Validate niPGT-A Clinical Benefit.

> **NCT04000152** · NA · TERMINATED · sponsor: **Igenomix** · enrollment: 296 (actual)

## Conditions studied

- Aneuploidy
- Chromosome Abnormality
- Infertility

## Interventions

- **DIAGNOSTIC_TEST:** niPGT-A
- **OTHER:** Morphology criteria

## Key facts

- **NCT ID:** NCT04000152
- **Lead sponsor:** Igenomix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-29
- **Primary completion:** 2025-04-18
- **Final completion:** 2025-04-18
- **Target enrollment:** 296 (ACTUAL)
- **Why stopped:** The recruitment was halted on Mar 1st 2024, after the Data Monitoring Committee, due to low recruitment speed and sustained high dropout rate. Other elements impacted negatively, including the SARS-COV-2 pandemic or the inability to include new sites
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04000152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04000152, "RCT Study to Validate niPGT-A Clinical Benefit.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04000152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*